WESTBURY, N.Y., Nov. 20, 2012 -- /PRNewswire/ -- Vasomedical, Inc. (“Vasomedical”) (OTCQB: VASO) today reported its operating results for the three- and nine-month periods ended September 30, 2012.
“We reported another strong quarter of sales for our equipment segment in the third quarter. However, changes to certain sales commission milestones for 2012 compared to 2011 have resulted in a third quarter year-over-year revenue comparison that is non-reflective of our actual performance. As such, we believe that the comparison of our revenue for the nine-month periods ended September 30, 2012 and 2011 offers a more accurate representation of our sales growth. For the nine months ended September 30, 2012, the Company reported a 17.6% increase in total revenue, compared to the same period last year,” commented Dr. Jun Ma, President and Chief Executive Officer of Vasomedical, Inc. “We will continue to pursue additional opportunities to expand our equipment segment and explore avenues to grow our sales representation business.”
